Classic congenital adrenal hyperplasia, more commonly called classic CAH, is when there is an enzyme missing in the adrenal gland, which causes the body to have the inability to make enough cortisol.

Cardinal Health (CAH) has surged to a new 52-week high of $136.44 per share, reflecting a robust ascent that defies the notion of “too late to buy.” With a market cap of $33 billion ...

In this article, we are going to take a look at where Cardinal Health, Inc. (NYSE:CAH) stands against other growing dividend stocks. Value stocks are enjoying a rare period of strength amid this ...

Below is Validea's guru fundamental report for CARDINAL HEALTH INC (CAH). Of the 22 guru strategies we follow, CAH rates highest using our Multi-Factor Investor model based on the published ...

Sexual precocity and a testicular mass can result from a Leydig cell tumor or from simple virilizing CAH with adrenal rests in the testes. These diagnoses are usually distinguished by very high ...

Citi analyst Daniel Grosslight maintained a Hold rating on Cardinal Health (CAH – Research Report) today and set a price target of $140.00. The company’s shares closed yesterday at $134.36.

CAH stock opened at $137.20 on Monday. Cardinal Health has a 1 year low of $93.17 and a 1 year high of $138.62. The stock has a market capitalization of $33.14 billion, a price-to-earnings ratio ...